Skip Navigation

Cardiovascular Research 2003 58(2):351-357; doi:10.1016/S0008-6363(02)00769-1
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Menasché, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Menasché, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

Skeletal muscle satellite cell transplantation

Philippe Menasché*

Department of Cardiovascular Surgery, Hôpital Européen Georges Pompidou, 20, rue Leblanc, 75015 Paris, France

* Tel.: +33-1-4025-6721; fax: +33-1-4025-6754. philippe.menasche{at}hop.egp.ap-hop-paris.fr

Cell transplantation is currently gaining a growing interest as a potential new means of improving the prognosis of patients with cardiac failure. The basic assumption is that left ventricular dysfunction is primarily caused by the loss of a critical number of cardiomyocytes and that their replacement by new contractile cells could functionally ‘regenerate’ postinfarction scars in which these cells are implanted. Primarily for practical reasons, autologous skeletal myoblasts have been the first to undergo clinical trials but other cell types are also considered, particularly bone marrow stem cells which are attractive because of their autologous origin and their purported cardiomyocyte/endothelial transdifferentiation potential in response to cues present in the target organ. However, several key issues still need to be addressed including (1) the optimal type of donor cells, (2) the mechanism by which cell engraftment improves cardiac function, (3) the optimization of cell survival, and (4) the potential benefits of cell transplantation in nonischemic dilated cardiomyopathies. In parallel to the experimental studies designed to address these issues, clinical trials are underway and their results should hopefully allow the assessment of to what extent cellular therapy may improve the outcome of patients with heart failure.

KEYWORDS Heart failure; Stem cells; Transplantation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart JHome page
J. J. Gavira, E. Nasarre, G. Abizanda, M. Perez-Ilzarbe, A. de Martino-Rodriguez, J. A. Garcia de Jalon, M. Mazo, A. Macias, I. Garcia-Bolao, B. Pelacho, et al.
Repeated implantation of skeletal myoblast in a swine model of chronic myocardial infarction
Eur. Heart J., August 22, 2009; (2009) ehp342v1.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
N. Dib, J. Dinsmore, Z. Lababidi, B. White, S. Moravec, A. Campbell, A. Rosenbaum, K. Seyedmadani, W. A. Jaber, C. S. Rizenhour, et al.
One-Year Follow-Up of Feasibility and Safety of the First U.S., Randomized, Controlled Study Using 3-Dimensional Guided Catheter-Based Delivery of Autologous Skeletal Myoblasts for Ischemic Cardiomyopathy (CAuSMIC Study)
J. Am. Coll. Cardiol. Intv., January 1, 2009; 2(1): 9 - 16.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
J. J. Gavira, G. Abizanda, M. Perez-Ilzarbe, D. Martinez-Caro, E. Nasarre, A. Perez-Ruiz, and F. Prosper
Skeletal myoblasts for cardiac repair in animal models
Eur. Heart J. Suppl., December 1, 2008; 10(suppl_K): K11 - K15.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
J. J. Gavira, M. Perez-Ilzarbe, G. Abizanda, A. Garcia-Rodriguez, J. Orbe, J. A. Paramo, M. Belzunce, G. Rabago, J. Barba, J. Herreros, et al.
A comparison between percutaneous and surgical transplantation of autologous skeletal myoblasts in a swine model of chronic myocardial infarction
Cardiovasc Res, September 1, 2006; 71(4): 744 - 753.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
T. M. Kolettis
Arrhythmogenesis after cell transplantation post-myocardial infarction. Four burning questions-And some answers
Cardiovasc Res, February 1, 2006; 69(2): 299 - 301.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. Fernandes, J.-C. Amirault, G. Lande, J.-M. Nguyen, V. Forest, O. Bignolais, G. Lamirault, D. Heudes, J.-L. Orsonneau, M.-F. Heymann, et al.
Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias
Cardiovasc Res, February 1, 2006; 69(2): 348 - 358.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
Y. Itabashi, S. Miyoshi, S. Yuasa, J. Fujita, T. Shimizu, T. Okano, K. Fukuda, and S. Ogawa
Analysis of the electrophysiological properties and arrhythmias in directly contacted skeletal and cardiac muscle cell sheets
Cardiovasc Res, August 15, 2005; 67(3): 561 - 570.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.